Afya Limited (NASDAQ:AFYA) Receives Consensus Recommendation of “Hold” from Brokerages

Afya Limited (NASDAQ:AFYAGet Free Report) has been assigned a consensus recommendation of “Hold” from the six analysts that are currently covering the firm, Marketbeat Ratings reports. Six investment analysts have rated the stock with a hold rating. The average twelve-month price objective among brokers that have covered the stock in the last year is $18.00.

AFYA has been the subject of several recent research reports. Bank of America reiterated a “neutral” rating on shares of Afya in a research report on Thursday, June 11th. Weiss Ratings cut shares of Afya from a “hold (c)” rating to a “hold (c-)” rating in a report on Friday, July 31st. JPMorgan Chase & Co. decreased their target price on shares of Afya from $21.50 to $21.00 and set a “neutral” rating on the stock in a research note on Monday, June 22nd. Wall Street Zen cut shares of Afya from a “strong-buy” rating to a “buy” rating in a research report on Saturday, May 2nd. Finally, Zacks Research lowered shares of Afya from a “strong-buy” rating to a “hold” rating in a report on Wednesday, May 6th.

Check Out Our Latest Stock Analysis on AFYA

Insider Transactions at Afya

In other Afya news, VP Lelio De Souza Junior sold 36,204 shares of the company’s stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $15.00, for a total transaction of $543,060.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, VP Gomiero Mirella Basolli sold 10,000 shares of the stock in a transaction that occurred on Friday, June 26th. The stock was sold at an average price of $14.80, for a total value of $148,000.00. Following the completion of the sale, the vice president owned 34,530 shares of the company’s stock, valued at approximately $511,044. This trade represents a 22.46% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 87,745 shares of company stock valued at $1,314,175. 0.80% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Afya

Several hedge funds have recently made changes to their positions in AFYA. Van ECK Associates Corp lifted its stake in Afya by 15.7% in the third quarter. Van ECK Associates Corp now owns 10,170 shares of the company’s stock worth $159,000 after acquiring an additional 1,377 shares during the period. Daiwa Securities Group Inc. bought a new stake in Afya in the fourth quarter valued at $43,000. Arrowstreet Capital Limited Partnership increased its position in Afya by 5.6% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 68,169 shares of the company’s stock valued at $1,217,000 after purchasing an additional 3,626 shares during the period. Militia Capital Partners LP purchased a new position in Afya during the 2nd quarter valued at $71,000. Finally, Fairtree Asset Management Pty Ltd raised its holdings in Afya by 22.3% in the 4th quarter. Fairtree Asset Management Pty Ltd now owns 30,697 shares of the company’s stock worth $473,000 after purchasing an additional 5,599 shares in the last quarter. 88.02% of the stock is owned by hedge funds and other institutional investors.

Afya Trading Down 2.2%

Shares of AFYA stock opened at $13.63 on Thursday. The business has a 50-day moving average of $14.35 and a 200 day moving average of $14.43. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.78 and a quick ratio of 1.78. Afya has a 1-year low of $13.00 and a 1-year high of $16.50. The stock has a market capitalization of $1.28 billion, a PE ratio of 8.91, a P/E/G ratio of 1.38 and a beta of 0.34.

Afya Company Profile

(Get Free Report)

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.

Further Reading

Analyst Recommendations for Afya (NASDAQ:AFYA)

Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.